CARLSBAD, Calif., Jan. 17, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today it will report its fourth quarter and full year 2011 financial results and provide guidance for 2012 on Tuesday, February 7, 2012, after market close. The company will also hold a webcast on the same day at 4:30 p.m. ET to discuss operating results, as well as future expectations.
(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)
The webcast can be accessed through the investor relations page of the Life Technologies website at ir.lifetechnologies.com/events.cfm. A replay of the webcast will be available on the Company’s website through Tuesday, February 28, 2012.
About Life Technologies (www.lifetechnologies.com)
Life Technologies Corporation is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies’ industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and TaqMan® products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 4,000 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.
Contact Information:
Investor Relations
760-603-7208
ir@lifetech.com
SOURCE Life Technologies
